NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
1-Year Return
32.9%
This Quarter Return
+11.66%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$1.41B
AUM Growth
+$204M
(+17%)
Cap. Flow
+$59.3M
Cap. Flow
% of AUM
4.19%
Top 10 Holdings %
Top 10 Hldgs %
37.13%
Holding
155
New
17
Increased
44
Reduced
11
Closed
8
Top Buys
| 1 |
Xtant Medical Holdings
XTNT
|
+$42.1M |
| 2 |
JCAP
Jefferson Capital, Inc. Common Stock
JCAP
|
+$11.1M |
| 3 |
TriSalus Life Sciences
TLSI
|
+$10.9M |
| 4 |
Jack in the Box
JACK
|
+$10.5M |
| 5 |
1-800-Flowers.com
FLWS
|
+$9.84M |
Top Sells
| 1 |
Soleno Therapeutics
SLNO
|
+$63.3M |
| 2 |
Gogo Inc
GOGO
|
+$37M |
| 3 |
UroGen Pharma
URGN
|
+$18.6M |
| 4 |
RH
RH
|
+$11.8M |
| 5 |
uniQure
QURE
|
+$9.82M |
Sector Composition
| 1 | Healthcare | 63.53% |
| 2 | Consumer Discretionary | 15.72% |
| 3 | Communication Services | 5.76% |
| 4 | Financials | 5.29% |
| 5 | Industrials | 3.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
151
RH
RH
$4.36B
| – | – |
-50,158
| Closed | -$11.8M |
|
152
Teva Pharmaceuticals
TEVA
$22.6B
| – | – |
0
| – | – |
|
153
Viatris
VTRS
$12.2B
| – | – |
0
| – | – |
|
154
SPDR S&P Biotech ETF
XBI
$5.48B
| – | – |
0
| – | – |
|
155
Zynex
ZYXI
$45.4M
| – | – |
-487,778
| Closed | -$1.07M |
|